Zongfang Li

4.1k total citations
96 papers, 2.3k citations indexed

About

Zongfang Li is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Zongfang Li has authored 96 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 31 papers in Epidemiology and 21 papers in Hepatology. Recurrent topics in Zongfang Li's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (13 papers) and Liver physiology and pathology (8 papers). Zongfang Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (13 papers) and Liver physiology and pathology (8 papers). Zongfang Li collaborates with scholars based in China, United States and United Kingdom. Zongfang Li's co-authors include Jun Yang, Shu Zhang, Malgorzata Garstka, Baohua Li, Jin Sun, Chen Huang, Wei Jiang, Beibei Bie, Rui Zhou and Ying Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Zongfang Li

93 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zongfang Li China 29 873 436 429 377 367 96 2.3k
Shi-Bing Su China 30 1.3k 1.5× 538 1.2× 248 0.6× 540 1.4× 344 0.9× 125 2.9k
Meei‐Ling Sheu Taiwan 36 1.1k 1.3× 568 1.3× 360 0.8× 335 0.9× 227 0.6× 101 3.2k
Christoph Dorn Germany 33 1.2k 1.4× 1.1k 2.5× 582 1.4× 243 0.6× 313 0.9× 125 3.9k
Feifei Guo China 22 1.5k 1.8× 423 1.0× 261 0.6× 300 0.8× 208 0.6× 95 2.7k
Eric A.G. Blomme United States 30 1.2k 1.4× 216 0.5× 270 0.6× 506 1.3× 266 0.7× 77 3.3k
Xuanbin Wang China 29 1.1k 1.3× 272 0.6× 388 0.9× 343 0.9× 363 1.0× 83 2.4k
Hiroko Shimizu Japan 30 1.5k 1.7× 319 0.7× 444 1.0× 448 1.2× 410 1.1× 99 2.8k
Xianglu Rong China 27 1.5k 1.7× 518 1.2× 690 1.6× 187 0.5× 188 0.5× 76 3.2k

Countries citing papers authored by Zongfang Li

Since Specialization
Citations

This map shows the geographic impact of Zongfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongfang Li more than expected).

Fields of papers citing papers by Zongfang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongfang Li. The network helps show where Zongfang Li may publish in the future.

Co-authorship network of co-authors of Zongfang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zongfang Li. A scholar is included among the top collaborators of Zongfang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongfang Li. Zongfang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Li‐Min, Zeyu Li, Zeyu Li, et al.. (2025). DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC. Neoplasia. 67. 101198–101198. 1 indexed citations
2.
Li, Zeyu, Fei Du, Nanbin Liu, et al.. (2025). Macrophage DHX34 as a negative regulator of the CX3CL1–CX3CR1 axis and CD8+ T-cell infiltration in hepatocellular carcinoma. International Immunopharmacology. 169. 116014–116014.
3.
Wei, Dong, Chongyu Zhang, Jin Sun, et al.. (2024). Activation of MEK‐ERK‐c‐MYC signaling pathway promotes splenic M2-like macrophage polarization to inhibit PHcH-liver cirrhosis. Frontiers in Immunology. 15. 1417521–1417521.
4.
Han, Jinhua, et al.. (2023). Fibrillarin promotes homologous recombination repair by facilitating the recruitment of recombinase RAD51 to DNA damage sites. Journal of Zhejiang University SCIENCE B. 24(12). 1165–1173. 2 indexed citations
5.
Li, Suxin, Na Huang, Xiaowei Dang, et al.. (2020). A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism. Viral Immunology. 33(2). 112–121. 1 indexed citations
6.
Zheng, Zhongqiang, Huan Wang, Liang Li, et al.. (2020). Splenectomy enhances the Ly6Clow phenotype in hepatic macrophages by activating the ERK1/2 pathway during liver fibrosis. International Immunopharmacology. 86. 106762–106762. 14 indexed citations
7.
Li, Baohua, Wei Jiang, Shu Zhang, et al.. (2020). The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice. Molecular Immunology. 125. 95–103. 17 indexed citations
8.
Jiang, Wei, Li Yu, Zhenzhen Li, et al.. (2019). Chronic restraint stress promotes hepatocellular carcinoma growth by mobilizing splenic myeloid cells through activating β-adrenergic signaling. Brain Behavior and Immunity. 80. 825–838. 45 indexed citations
9.
Huang, Na, Fanpu Ji, Shu Zhang, et al.. (2018). Effect of Splenectomy on Serum Cytokine Profiles in Hepatitis B Virus-Related Cirrhosis Patients with Portal Hypertension. Viral Immunology. 31(5). 371–378. 9 indexed citations
10.
Li, Jun, Rui Zhou, Beibei Bie, et al.. (2018). Emodin and baicalein inhibit sodium taurocholate-induced vacuole formation in pancreatic acinar cells. World Journal of Gastroenterology. 24(1). 35–45. 14 indexed citations
11.
Huang, Tianhe, Jie Lian, Fuling Zhou, et al.. (2017). Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer. Future Oncology. 13(17). 1493–1503. 5 indexed citations
12.
Li, Yu, Wei Jiang, Zhenzhen Li, et al.. (2017). Repetitive restraint stress changes spleen immune cell subsets through glucocorticoid receptor or β-adrenergic receptor in a stage dependent manner. Biochemical and Biophysical Research Communications. 495(1). 1108–1114. 38 indexed citations
13.
Wei, Wei, Yansong Pu, Rui Zhou, et al.. (2017). Wall shear stress in portal vein of cirrhotic patients with portal hypertension. World Journal of Gastroenterology. 23(18). 3279–3279. 21 indexed citations
14.
Yang, Jun, Xiaozhong Huang, Rui Guo, et al.. (2016). [p16INK4a protein is a specific molecular biomarker of breast cancer].. PubMed. 36(6). 751–5. 2 indexed citations
15.
Ji, Fanpu, Shuangsuo Dang, Zhifang Cai, et al.. (2015). [Antiviral treatment and long-term clinical outcome of decompensated cirrhotic patients with hepatitis C virus infection].. PubMed. 23(9). 647–52. 4 indexed citations
16.
17.
Li, Zongfang & Shu Zhang. (2009). [Changes in splenic macrophage function of hypersplenism due to portal hypertension].. PubMed. 47(2). 89–91. 2 indexed citations
18.
Li, Zongfang, Shu Zhang, Chen Huang, et al.. (2008). MicroRNAome of Splenic Macrophages in Hypersplenism due to Portal Hypertension in Hepatitis B Virus-Related Cirrhosis. Experimental Biology and Medicine. 233(11). 1454–1461. 15 indexed citations
19.
Dai, Zhijun, et al.. (2007). [HER-2 expression in local advanced breast cancer and the efficacy of neoadjuvant chemotherapy regimens].. PubMed. 27(9). 1397–9. 4 indexed citations
20.
Li, Zongfang. (2002). Splenic macrophage in the occurrence of hypersplenism in patients with portal hypertension. Zhonghua putong waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shi-Bing Su Breakdown of academic impact, for papers by Meei‐Ling Sheu Breakdown of academic impact, for papers by Christoph Dorn Breakdown of academic impact, for papers by Feifei Guo Breakdown of academic impact, for papers by Eric A.G. Blomme Breakdown of academic impact, for papers by Xuanbin Wang Breakdown of academic impact, for papers by Hiroko Shimizu Breakdown of academic impact, for papers by Xianglu Rong
Rankless by CCL
2026